Upgrades for even more efficient stereotactic workflow with Elekta Synergy will be displayed at ASTRO. Medical Intelligence, an Elekta company, will display the non-invasive HeadFIX(R) and BodyFIX(R) patient-specific immobilization devices, which are vacuum-activated for highly accurate and reproducible positioning and immobilization. Elekta is showing three new micro multileaf collimators (MLCs), the most versatile technology available for SRS and SRT. All three micro MLCs - the 3mm, the 5mm and the 7mm leaf width - have improved dose shaping abilities for minimal risk to critical organs.
Illustrious history, solid future in stereotaxy
"Elekta's stereotactic products demonstrate its commitment to technological innovation and advances in stereotaxy," says Puusepp. Elekta was founded by the late professor Lars Leksell, a pioneer in minimally invasive surgery and inventor of the Leksell Stereotactic System(R) in 1948 and Leksell Gamma Knife in 1968. Since, Elekta has continued to set new standards in accuracy and therapeutic efficacy in both stereotactic radiation therapy and stereotactic radiosurgery.
"As Elekta develops high quality cost-effective solutions, cancer centers around the world are taking a major interest in adding whole-body radiosurgery to their radiation therapy capabilities," says Puusepp.
Elekta is an international medical technology group, providing oncologists, radiation therapists, neurosurgeons and many other medical specialists with state of the art tools to fight serious disease.
Elekta provides advanced clinical solutions, comprehensive management and information systems as well as services for improved cancer care and management of brain disorders.
Elekta's systems and solutions are used in over 4,500 hospital
|SOURCE Elekta, Inc.|
Copyright©2007 PR Newswire.
All rights reserved